MARKET

CSTL

CSTL

Castle Biosciences
NASDAQ
36.02
+0.21
+0.57%
Opening 12:48 09/28 EDT
OPEN
35.81
PREV CLOSE
35.81
HIGH
36.05
LOW
35.12
VOLUME
76.64K
TURNOVER
--
52 WEEK HIGH
44.28
52 WEEK LOW
17.72
MARKET CAP
1.10B
P/E (TTM)
-55.3736
1D
5D
1M
3M
1Y
5Y
1D
Castle Biosciences: Study shows TissueCypher test changed management
TipRanks · 5h ago
Weekly Report: what happened at CSTL last week (0921-0925)?
Weekly Report · 7h ago
Castle Biosciences Announces Publication Of New Study Highlighting Demand For Molecular Testing In Atopic Dermatitis
Benzinga · 3d ago
Roth MKM Keeps Their Buy Rating on Castle Biosciences (CSTL)
TipRanks · 6d ago
Castle Biosciences Announces Opening Of New Laboratory And Office Facility In Scottsdale, Arizona
Benzinga · 6d ago
Castle Biosciences to open new laboratory facility in Scottsdale, Arizona
TipRanks · 6d ago
Castle Biosciences management to meet with BTIG
TipRanks · 6d ago
Weekly Report: what happened at CSTL last week (0914-0918)?
Weekly Report · 09/21 09:45
More
About CSTL
Castle Biosciences, Inc. is a molecular diagnostics company offering test solutions to aid clinicians in the diagnosis and treatment of dermatologic cancers, Barrett’s esophagus (BE), uveal melanoma (UM), and in the treatment of mental health conditions. The Company offers around six commercially available proprietary multi-analyte assays with algorithmic analysis (MAAA) tests for use in the fields of dermatology, gastroenterology ophthalmology and includes a test to guide systemic treatment decisions in patients with moderate-to-severe AD. It also offers a proprietary pharmacogenomic (PGx) test to guide optimal drug treatment for patients diagnosed with depression, anxiety and other mental health conditions. Its products include DecisionDx-Melanoma, DecisionDx-SCC, MyPath Melanoma, TissueCypher, IDgenetix, and DecisionDx-UM. DecisionDx-SCC is its proprietary gene expression profile (GEP) test for patients with cutaneous squamous cell carcinoma (SCC).

Webull offers Castle Biosciences Inc stock information, including NASDAQ: CSTL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CSTL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CSTL stock methods without spending real money on the virtual paper trading platform.